Process View
The network for 'mitotic g1 s transition checkpoint' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
A cell cycle checkpoint that detects and negatively regulates progression from G1 to S phase as part of a mitotic cell cycle.
| Name | Description | Probability | Func Analog Organism |
|---|---|---|---|
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.996 | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.976 | |
| RB1 | retinoblastoma 1 | 0.960 | |
| XIAP | X-linked inhibitor of apoptosis | 0.923 | |
| CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.829 | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.811 | |
| TP53 | tumor protein p53 | 0.641 | |
| APAF1 | apoptotic peptidase activating factor 1 | 0.617 | |
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.550 | |
| CDK6 | cyclin-dependent kinase 6 | 0.493 | |
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.441 | |
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.438 | |
| RPA1 | replication protein A1, 70kDa | 0.437 | |
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.376 | |
| FAS | Fas (TNF receptor superfamily, member 6) | 0.376 | |
| CCND3 | cyclin D3 | 0.369 | |
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.287 | |
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.265 | |
| LRDD | leucine-rich repeats and death domain containing | 0.259 | |
| CCND1 | cyclin D1 | 0.245 | |
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.226 | |
| IER3 | immediate early response 3 | 0.215 | |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.198 | |
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.191 | |
| CDK2 | cyclin-dependent kinase 2 | 0.190 | |
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.186 | |
| PCGF2 | polycomb group ring finger 2 | 0.180 | |
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.147 | |
| WWOX | WW domain containing oxidoreductase | 0.144 | |
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.142 | |
| POU5F1 | POU class 5 homeobox 1 | 0.110 | |
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.109 | |
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.095 | |
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.093 | |
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.083 | |
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.079 | |
| POU3F2 | POU class 3 homeobox 2 | 0.066 | |
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.064 | |
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.053 | |
| BCL2 | B-cell CLL/lymphoma 2 | 0.053 | |
| PAX3 | paired box 3 | 0.047 | |
| HIPK2 | homeodomain interacting protein kinase 2 | 0.046 | |
| RBL2 | retinoblastoma-like 2 (p130) | 0.044 | |
| ARRB2 | arrestin, beta 2 | 0.043 | |
| PRNP | prion protein | 0.039 | |
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.038 | |
| BRCA1 | breast cancer 1, early onset | 0.037 | |
| FADD | Fas (TNFRSF6)-associated via death domain | 0.037 | |
| BIRC2 | baculoviral IAP repeat containing 2 | 0.034 | |
| UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | 0.033 | |
| FOXD3 | forkhead box D3 | 0.033 | |
| SKP1 | S-phase kinase-associated protein 1 | 0.033 | |
| MKRN1 | makorin ring finger protein 1 | 0.033 | |
| SMAD7 | SMAD family member 7 | 0.030 | |
| DAXX | death-domain associated protein | 0.030 | |
| CCND2 | cyclin D2 | 0.030 | |
| RBL1 | retinoblastoma-like 1 (p107) | 0.029 | |
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.027 | |
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.027 | |
| PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.026 | |
| CBLC | Cas-Br-M (murine) ecotropic retroviral transforming sequence c | 0.022 | |
| CCNE1 | cyclin E1 | 0.022 | |
| KRT5 | keratin 5 | 0.021 | |
| MED1 | mediator complex subunit 1 | 0.021 | |
| NOTCH1 | notch 1 | 0.020 | |
| NUCB2 | nucleobindin 2 | 0.020 | |
| SPRR2A | small proline-rich protein 2A | 0.020 | |
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.019 | |
| GORAB | golgin, RAB6-interacting | 0.018 | |
| RYBP | RING1 and YY1 binding protein | 0.018 | |
| CCNA1 | cyclin A1 | 0.018 | |
| PIM1 | pim-1 oncogene | 0.018 | |
| DIABLO | diablo, IAP-binding mitochondrial protein | 0.017 | |
| CSNK1A1 | casein kinase 1, alpha 1 | 0.016 | |
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.016 | |
| GSK3B | glycogen synthase kinase 3 beta | 0.015 | |
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.014 | |
| SGK3 | serum/glucocorticoid regulated kinase family, member 3 | 0.014 | |
| RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | 0.014 | |
| MARCKSL1 | MARCKS-like 1 | 0.014 | |
| SATB2 | SATB homeobox 2 | 0.014 | |
| YAP1 | Yes-associated protein 1 | 0.014 | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.013 | |
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.013 | |
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.013 | |
| RIOK3 | RIO kinase 3 (yeast) | 0.013 | |
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.013 | |
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.012 | |
| RPS27L | ribosomal protein S27-like | 0.012 | |
| UNG | uracil-DNA glycosylase | 0.011 | |
| E2F3 | E2F transcription factor 3 | 0.011 | |
| SALL2 | sal-like 2 (Drosophila) | 0.011 | |
| DZIP1 | DAZ interacting protein 1 | 0.011 | |
| PML | promyelocytic leukemia | 0.011 | |
| CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 0.010 | |
| CDK14 | cyclin-dependent kinase 14 | 0.010 |
| Name | Description | Probability | Func Analog Organism |
|---|---|---|---|
| wg | wingless | 0.010 |